Targeted &agr;1A-Adrenergic Receptor Overexpression Induces Enhanced Cardiac Contractility but not Hypertrophy
暂无分享,去创建一个
R. Graham | M. Feneley | E. Woodcock | S. Kesteven | W. Owens | F. Lin | Songhai Chen | M. Stevens | J. Arthur | Robert M. Graham | W. A. Owens | Mary E. Stevens | Jane F. Arthur | Elizabeth A. Woodcock
[1] P. Simpson,et al. Autonomous and growth factor-induced hypertrophy in cultured neonatal mouse cardiac myocytes. Comparison with rat. , 2000, Circulation research.
[2] E. Woodcock,et al. Adverse effects of constitutively active alpha(1B)-adrenergic receptors after pressure overload in mouse hearts. , 2000, American journal of physiology. Heart and circulatory physiology.
[3] J. Sadoshima,et al. Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro , 2000, Nature Medicine.
[4] N. Dali-Youcef,et al. Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. Michel,et al. Adrenergic and muscarinic receptors in the human heart. , 1999, Pharmacological reviews.
[6] M. Feneley,et al. Response of the intact canine left ventricle to increased afterload and increased coronary perfusion pressure in the presence of coronary flow autoregulation. , 1999, Circulation.
[7] J. Lorenz,et al. Abnormal Cardiac Structure and Function in Mice Expressing Nonphosphorylatable Cardiac Regulatory Myosin Light Chain 2* , 1999, The Journal of Biological Chemistry.
[8] Dimitrios Georgakopoulos,et al. The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation , 1999, Nature Medicine.
[9] E. Woodcock,et al. Reduced reperfusion-induced Ins(1,4,5)P3 generation and arrhythmias in hearts expressing constitutively active alpha1B-adrenergic receptors. , 1998, Circulation research.
[10] G. Boivin,et al. Overexpression of α1B-adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy. , 1998, American journal of physiology. Heart and circulatory physiology.
[11] E. Woodcock,et al. Selective activation of alpha1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of alpha1-adrenergic receptor subtype mRNAs. , 1998, Journal of molecular and cellular cardiology.
[12] G. Lembo,et al. Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Cho,et al. Transgenic Mice with Cardiac Overexpression of α1B-Adrenergic Receptors , 1997, The Journal of Biological Chemistry.
[14] E. Lakatta,et al. Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase. , 1997, Circulation research.
[15] G. Dorn,et al. Transgenic Gαq overexpression induces cardiac contractile failure in mice , 1997 .
[16] R. Graham,et al. α1-Adrenergic Receptor Signaling via Gh Is Subtype Specific and Independent of Its Transglutaminase Activity* , 1996, The Journal of Biological Chemistry.
[17] P. Sugden,et al. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. , 1996, Circulation research.
[18] R. Graham,et al. alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. , 1996, Circulation research.
[19] C. Long,et al. Alpha1-adrenergic receptor subtype mRNAs are differentially regulated by alpha1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. Repression of alpha1B and alpha1D but induction of alpha1C. , 1996, The Journal of biological chemistry.
[20] H. Suga,et al. Logistic time constant of isovolumic relaxation pressure-time curve in the canine left ventricle. Better alternative to exponential time constant. , 1995, Circulation.
[21] R. Lefkowitz,et al. Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[22] T. Doetschman,et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. , 1994, Circulation research.
[23] R. Lefkowitz,et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. , 1994, Science.
[24] R. Lefkowitz,et al. Enhanced Myocardial Function inTransgenic Mice Overexpressing theP2-Adrenergic Receptor , 1994 .
[25] A. Ardati,et al. A nuclear pathway for alpha 1‐adrenergic receptor signaling in cardiac cells. , 1993, The EMBO journal.
[26] K. Chien,et al. The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. , 1993, The Journal of biological chemistry.
[27] W. Little,et al. Comparison of measures of left ventricular contractile performance derived from pressure-volume loops in conscious dogs. , 1989, Circulation.